Panacea Biotec Limited (NSE:PANACEABIO)

Panacea Biotec Revenue

In the fiscal year ending March 31, 2026, Panacea Biotec had annual revenue of 6.40B INR with 14.43% growth. Panacea Biotec had revenue of 1.67B in the quarter ending March 31, 2026, with 25.82% growth.

• Revenue: 6.40B
• Revenue Growth: +14.43%
• P/S Ratio: 5.02
• Revenue / Employee: 2.98M
• Employees: 2,149
• Market Cap: 32.10B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	6.40B	806.76M	14.43%
Mar 31, 2025	5.59B	-740.00K	-0.01%
Mar 31, 2024	5.59B	992.22M	21.57%
Mar 31, 2023	4.60B	-2.01B	-30.44%
Mar 31, 2022	6.61B	364.27M	5.83%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 21, 2026

Data Sources Report a data error